InvestorsHub Logo
Followers 7
Posts 561
Boards Moderated 0
Alias Born 04/09/2018

Re: None

Thursday, 03/21/2019 10:28:47 PM

Thursday, March 21, 2019 10:28:47 PM

Post# of 3353
Biogen pulls out of phase 3 trial for Alzheimer’s. $BCLI has positive signs for their phase 3 ALS, has HE for ALS, started enrollment for MS, has Parkinson’s and Alzheimer’s in pipeline. Great acquisition target for big pharma. $800M-$2B target at this point, 10-30x returns!
https://www.cnbc.com/2019/03/21/biogen-shares-plunge-more-than-25percent-after-ending-trial-for-alzheimers-drug-aducanumab.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BCLI News